"Nanoparticles" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Nanometer-sized particles that are nanoscale in three dimensions. They include nanocrystaline materials; NANOCAPSULES; METAL NANOPARTICLES; DENDRIMERS, and QUANTUM DOTS. The uses of nanoparticles include DRUG DELIVERY SYSTEMS and cancer targeting and imaging.
| Descriptor ID |
D053758
|
| MeSH Number(s) |
J01.637.512.600
|
| Concept/Terms |
Nanocrystalline Materials- Nanocrystalline Materials
- Material, Nanocrystalline
- Materials, Nanocrystalline
- Nanocrystalline Material
- Nanocrystals
- Nanocrystal
|
Below are MeSH descriptors whose meaning is more general than "Nanoparticles".
Below are MeSH descriptors whose meaning is more specific than "Nanoparticles".
This graph shows the total number of publications written about "Nanoparticles" by people in this website by year, and whether "Nanoparticles" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 2 | 2 | 4 |
| 2007 | 5 | 0 | 5 |
| 2008 | 3 | 0 | 3 |
| 2009 | 1 | 1 | 2 |
| 2010 | 8 | 2 | 10 |
| 2011 | 5 | 2 | 7 |
| 2012 | 7 | 0 | 7 |
| 2013 | 7 | 0 | 7 |
| 2014 | 4 | 3 | 7 |
| 2015 | 6 | 2 | 8 |
| 2016 | 8 | 3 | 11 |
| 2017 | 5 | 2 | 7 |
| 2018 | 5 | 1 | 6 |
| 2019 | 4 | 4 | 8 |
| 2020 | 3 | 3 | 6 |
| 2021 | 7 | 1 | 8 |
| 2022 | 3 | 0 | 3 |
| 2023 | 3 | 1 | 4 |
| 2024 | 4 | 1 | 5 |
| 2025 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nanoparticles" by people in Profiles.
-
Transforming malignant tumors into vulnerable phenotypes via nanoscale coordination polymer mediated cell senescence and photodynamic therapy. Biomaterials. 2025 Nov; 322:123355.
-
Nanoparticle-Mediated Toll-Like Receptor Activation and Dual Immune Checkpoint Downregulation for Potent Cancer Immunotherapy. ACS Nano. 2025 03 11; 19(9):8852-8866.
-
Highly disordered and resorbable lithiated nanoparticles with osteogenic and angiogenic properties. J Mater Chem B. 2024 Oct 02; 12(38):9575-9591.
-
STING activation disrupts tumor vasculature to overcome the EPR limitation and increase drug deposition. Sci Adv. 2024 Jul 19; 10(29):eado0082.
-
Mitochondria-Targeted Multifunctional Nanoparticles Combine Cuproptosis and Programmed Cell Death-1 Downregulation for Cancer Immunotherapy. Adv Sci (Weinh). 2024 Sep; 11(35):e2403520.
-
Microglia-targeted inhibition of miR-17 via mannose-coated lipid nanoparticles improves pathology and behavior in a mouse model of Alzheimer's disease. Brain Behav Immun. 2024 Jul; 119:919-944.
-
Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy. Adv Sci (Weinh). 2024 Jun; 11(23):e2310309.
-
Toward a Nanoencapsulated EPR Imaging Agent for Clinical Use. Mol Imaging Biol. 2024 Jun; 26(3):525-541.
-
STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy. Sci Immunol. 2023 05 12; 8(83):eadd1153.
-
Nanoparticle-Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy. Adv Mater. 2023 May; 35(21):e2206370.